D. E. Shaw & Co., Inc.
- SEC CIK
- 0001009207
- Latest filing
- Aug 14, 2026
GH holding history
Guardant Health, Inc. in every 13F filed by D. E. Shaw & Co., Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
GH overviewAll 13F holders of GHFull Q2 2026 holdings
- Shares (Q2 2026)
- 1,255,658
- Value
- $188.4M
- % of portfolio
- 0.1%
- Quarters held
- 12
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 1,255,658 | $188.4M | 0.1% | +828,183+193.7% | Added | Holders |
| Q1 2026 | 427,475 | $39.5M | <0.1% | −195,582−31.4% | Reduced | Holders |
| Q4 2025 | 623,057 | $63.6M | <0.1% | +589,710+1,768.4% | Added | Holders |
| Q3 2025 | 33,347 | $2.08M | <0.1% | +33,347 | New | Holders |
| Q2 2024 | 0 | $0 | 0.0% | −109,943−100.0% | Sold out | Holders |
| Q1 2024 | 109,943 | $2.27M | <0.1% | −26,086−19.2% | Reduced | Holders |
| Q4 2023 | 136,029 | $3.68M | <0.1% | −90,063−39.8% | Reduced | Holders |
| Q3 2023 | 226,092 | $6.70M | <0.1% | +226,092 | New | Holders |
| Q2 2023 | 0 | $0 | 0.0% | −490,671−100.0% | Sold out | Holders |
| Q1 2023 | 490,671 | $11.5M | <0.1% | +490,671 | New | Holders |
| Q3 2022 | 0 | $0 | 0.0% | −9,400−100.0% | Sold out | Holders |
| Q2 2022 | 9,400 | $379.0K | <0.1% | +9,400 | New | Holders |
| Q4 2021 | 0 | $0 | 0.0% | −71,604−100.0% | Sold out | Holders |
| Q3 2021 | 71,604 | $8.95M | <0.1% | −157,128−68.7% | Reduced | Holders |
| Q2 2021 | 228,732 | $28.4M | <0.1% | −39,970−14.9% | Reduced | Holders |
| Q1 2021 | 268,702 | $41.0M | 0.1% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.